Effect of different non-invasive ventilation modes combined with ambroxol in the treatment of respiratory distress syndrome in premature infants

ZHOU Yanling; LIN Jian; FU Yiying; WANG Hua

doi:10.7619/jcmp.20223818

Journal of Clinical Medicine in Practice > 2023 > 27(11): 55-58. > DOI: 10.7619/jcmp.20223818

ZHOU Yanling, LIN Jian, FU Yiying, WANG Hua. Effect of different non-invasive ventilation modes combined with ambroxol in the treatment of respiratory distress syndrome in premature infants[J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 55-58. DOI: 10.7619/jcmp.20223818

Citation:

PDF (634 KB)

Effect of different non-invasive ventilation modes combined with ambroxol in the treatment of respiratory distress syndrome in premature infants

Department of Pediatrics, Haikou City People′s Hospital of Hainan Province, Haikou, Hainan, 570208

More Information

Received Date: December 22, 2022
Revised Date: April 10, 2023
Available Online: June 24, 2023

Graphical Abstract

Abstract

Abstract

Objective
To observe the clinical effect of different non-invasive auxiliary ventilation modes combined with ambroxol in the treatment of neonatal respiratory distress syndrome (NRDS).
Methods
The clinical data of 120 premature infants with NRDS admitted to the neonatal intensive care unit from January 2020 to March 2022 were analyzed. All of them were treated with non-invasive auxiliary ventilation on the basis of ambroxol, and were divided into nasal continuous positive airway pressure (nCPAP) group and bi-level positive airway pressure (BiPAP) group according to the ventilation modes, with 60 patients in each group. The artery blood gas analysis indexes of the two groups after 24 h after ventilation treatment as well as oxygen treatment time, hospital stay, non-invasive ventilation time and the incidence of complications were compared.
Results
The arterial partial pressure of oxygen[p_a(O₂)]and oxygen index (OI) in the BiPAP group were higher than those in the nCPAP group, and the arterial partial pressure of carbon dioxide [p_a(CO₂)]was lower than that in the nCPAP group (P < 0.05). The duration of oxygen therapy and hospital stay in the BiPAP group were shorter than those in the nCPAP group (P < 0.05). There was no significant difference in the duration of non-invasive ventilation between the two groups (P>0.05). The incidence of bronchopulmonary dysplasia (BPD) in the BiPAP group was lower than that in the nCPAP group (P < 0.05). There were no significant differences in the incidence of pulmonary infection, intracranial hemorrhage, patent ductus arteriosus (PDA), pneumothorax, retinopathy of prematurity (ROP) and tracheal intubation between two groups (P>0.05).
Conclusion
Compared with nCPAP combined with ambroxol, BiPAP combined with ambroxol applied in premature infants with NRDS respiratory support can more effectively improve the arterial blood gas level of premature infants, reduce the incidence of BPD and shorten the length of hospital stay.

FullText(HTML)

References (20)

References

[1]	XIANG J J, WANG P. Efficacy of pulmonary surfactant combined with high-dose ambroxol hydrochloride in the treatment of neonatal respiratory distress syndrome[J]. Exp Ther Med, 2019, 18(1): 654-658.
[2]	YOU H X, HUANG X N. Effect of pulmonary surfactant on the prevention of neonatal respiratory distress syndrome in premature infants[J]. Am J Transl Res, 2021, 13(4): 3642-3649.
[3]	卢隽滢, 卢红艳, 常明, 等. 不同无创通气模式在早产儿呼吸窘迫综合征撤机后的应用比较[J]. 实用医学杂志, 2020, 36(20): 2797-2801. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ202020010.htm
[4]	李建梁, 柯小莲, 陈东昀. 持续气道正压通气联合氨溴索治疗新生儿呼吸窘迫综合征的疗效分析[J]. 实用临床医药杂志, 2020, 24(14): 76-78. doi: 10.7619/jcmp.202014020
[5]	RONG Z H, LI W B, LIU W, et al. Nasal bi-level positive airway pressure (BiPAP) versus nasal continuous positive airway pressure (CPAP) in preterm infants ≤32 weeks: a retrospective cohort study[J]. J Paediatr Child Health, 2016, 52(5): 493-498. doi: 10.1111/jpc.13175
[6]	陈美华, 钟玉, 顾志本. 氨溴索联合不同通气方式治疗早产儿呼吸窘迫综合征临床效果的比较[J]. 临床肺科杂志, 2019, 24(6): 1046-1049. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFK201906021.htm
[7]	邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 5版. 北京: 人民卫生出版社, 2019: 112-116.
[8]	中华医学会儿科学分会新生儿学组. 早产儿无创呼吸支持临床应用建议[J]. 中华儿科杂志, 2018, 56(9): 643-647. doi: 10.3760/cma.j.issn.0578-1310.2018.09.002
[9]	WANG J J, ZHANG L, CAI N. A comparative study of the efficacy and safety of high-flow nasal cannula and nasal continuous positive airway pressure in neonatal respiratory distress syndrome[J]. Medicine, 2022, 101(15): e29109. doi: 10.1097/MD.0000000000029109
[10]	谢伊玲, 杨勇, 黎晓燕. 经鼻间歇正压通气和经鼻持续气道正压通气治疗早产儿呼吸暂停的临床效果比较[J]. 临床医学工程, 2021, 28(12): 1609-1610. https://www.cnki.com.cn/Article/CJFDTOTAL-YBQJ202112009.htm
[11]	CHEN C, TIAN T, LIU L, et al. Gender-related efficacy of pulmonary surfactant in infants with respiratory distress syndrome: a STROBE compliant study[J]. Medicine, 2018, 97(17): e0425. doi: 10.1097/MD.0000000000010425
[12]	郝文东, 王国芳, 张彩莲. 双水平气道正压通气联合布地奈德福莫特罗对慢性阻塞性肺疾病急性加重合并Ⅱ型呼吸衰竭患者肺康复作用[J]. 中国老年学杂志, 2019, 39(3): 560-562. doi: 10.3969/j.issn.1005-9202.2019.03.018
[13]	LAMPLAND A L, PLUMM B, WORWA C, et al. Bi-level CPAP does not improve gas exchange when compared with conventional CPAP for the treatment of neonates recovering from respiratory distress syndrome[J]. Arch Dis Child Fetal Neonatal Ed, 2015, 100(1): F31-F34. doi: 10.1136/fetalneonatal-2013-305665
[14]	柳慧. 猪肺磷脂注射液联合氨溴索治疗新生儿呼吸窘迫综合征的效果[J]. 中国实用医刊, 2021, 48(8): 94-97. https://www.cnki.com.cn/Article/CJFDTOTAL-BFYX202212026.htm
[15]	ZHOU B, ZHAI J F, WU J B, et al. Different ventilation modes combined with ambroxol in the treatment of respiratory distress syndrome in premature infants[J]. Exp Ther Med, 2017, 13(2): 629-633.
[16]	SOLEVÅG A L, CHEUNG P Y, SCHMÖLZER G M. Bi-level noninvasive ventilation in neonatal respiratory distress syndrome. A systematic review and meta-analysis[J]. Neonatology, 2021, 118(3): 264-273.
[17]	CAPASSO L, BORRELLI A C, CERULLO J, et al. Reducing post-extubation failure rates in very preterm infants: is BiPAP better than CPAP[J]. J Matern Fetal Neonatal Med, 2022, 35(7): 1272-1277.
[18]	马秀慧, 金宝, 雷红林, 等. 微创肺表面活性物质注入技术联合双水平气道正压通气治疗早产儿呼吸窘迫综合征[J]. 中华新生儿科杂志: 中英文, 2022, 37(4): 298-304. https://www.cnki.com.cn/Article/CJFDTOTAL-EKYX202112014.htm
[19]	滕文哲, 陈虎, 石思瑶, 等. 双水平正压通气治疗慢性阻塞性肺疾病急性加重期并发Ⅱ型呼吸衰竭效果的Meta分析与试验序贯分析[J]. 中国全科医学, 2022, 25(2): 227-235. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202202012.htm
[20]	LIU Z, CHI J H, FENG Z C. Observation of curative effect of nasal continuous positive airway pressure combined with high-dose ambroxol for neonatal respiratory failure[J]. Pak J Pharm Sci, 2018, 4(Special): 1663-1666.

Cited By

Cited by

Periodical cited type(16)

1.	顾婷，顾圆，张敏. 小剂量红霉素联合孟鲁司特钠与布地奈德吸入剂治疗儿童难治性哮喘的临床效果. 中外医学研究. 2024(03): 114-118 .
2.	田兰，成晶，梁敏. 乙酰半胱氨酸联合罗红霉素治疗COPD并肺间质纤维化患者的临床疗效. 临床合理用药. 2024(12): 55-57 .
3.	贾毅，杨粉，贾南，卞伟妮，马歆花. N-乙酰半胱氨酸雾化吸入治疗婴幼儿支气管肺炎的效果分析. 中国实用医刊. 2024(24): 104-106 .
4.	杜德森. 复方异丙托溴铵联合乙酰半胱氨酸雾化吸入治疗慢性阻塞性肺病的效果. 临床医学. 2023(02): 99-101 .
5.	贺秋淼，李琳，贾玉萍. N-乙酰半胱氨酸联合多靶点干预对慢性阻塞性肺疾病合并肺间质纤维化患者肺功能的影响及安全性分析. 现代医学与健康研究电子杂志. 2023(14): 115-117 .
6.	田珅，仇桢. 罗红霉素联合N-乙酰半胱氨酸对慢性阻塞性肺疾病合并肺间质纤维化患者疗效及肺功能的影响. 中国药物经济学. 2023(08): 61-64 .
7.	韩红英，张敬富，罗敏. 黏液溶解剂雾化治疗对小儿呼吸系统疾病的促排痰作用及机理研究. 现代诊断与治疗. 2023(17): 2572-2574+2577 .
8.	邱饶元. 乙酰半胱氨酸联合罗红霉素治疗COPD合并肺间质纤维化对患者肺功能的影响. 临床合理用药杂志. 2022(26): 70-72 .
9.	张童，魏丽娟，严梅. 乙酰半胱氨酸联合Auto-CPAP治疗OSAHS的临床分析. 中华肺部疾病杂志(电子版). 2022(05): 703-705 .
10.	魏桂莲，崔彩云，张泽丽，马小军，侯占鑫. 吡非尼酮联合常规内科治疗在慢性阻塞性肺疾病继发肺间质纤维化病变的临床效果分析. 中外医学研究. 2022(32): 1-6 .
11.	李宁，陈谨，何耀红，朱婧，呼玮. COPD合并肺间质纤维化患者临床特点及血清TGF-β1、CTGF、TNF-α检测意义分析. 现代生物医学进展. 2022(24): 4644-4647+4626 .
12.	苏华. 小剂量罗红霉素联合舒利迭治疗的稳定期COPD的效果及对肺功能的影响. 世界复合医学. 2021(05): 131-133 .
13.	胡晨阳，翟成凯，翟飞，韩飞，朱琳琳. 大剂量N-乙酰半胱氨酸辅助治疗慢性阻塞性肺疾病并肺间质纤维化的效果及其对肺功能、炎性因子指标及血管内皮生长因子的影响. 中国医学工程. 2021(07): 126-128 .
14.	郑玉春，李伟霞. 乙酰半胱氨酸结合罗红霉素治疗慢性阻塞性肺疾病的临床研究. 哈尔滨医药. 2021(04): 40-41 .
15.	李雪，朱亚蕊，雷立锋，胡会杰. 乙酰半胱氨酸吡非尼酮辅助治疗特发性肺纤维化患者的效果及对基质金属蛋白酶的影响. 中国药物与临床. 2021(20): 3425-3427 .
16.	侯双燕. 噻托溴铵联合N-乙酰半胱氨酸治疗慢性阻塞性肺疾病稳定期的疗效观察. 中国现代药物应用. 2021(23): 90-92 .

Other cited types(1)

Get Citation

PDF

XML

Article views (149) PDF downloads (10) Cited by(17)

Turn off MathJax

Article Contents

Abstract

References

Effect of different non-invasive ventilation modes combined with ambroxol in the treatment of respiratory distress syndrome in premature infants

Abstract

References

Cited by

Periodical cited type(16)

Other cited types(1)

Catalog

Export File

Citation

Format

Content